Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 2/2021

24.08.2020 | Original Paper

Estimating the Effect of Depression on HIV Transmission Risk Behaviors Among People Who Inject Drugs in Vietnam: A Causal Approach

verfasst von: Sara N. Levintow, Brian W. Pence, Kimberly A. Powers, Teerada Sripaipan, Tran Viet Ha, Viet Anh Chu, Vu Minh Quan, Carl A. Latkin, Vivian F. Go

Erschienen in: AIDS and Behavior | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

The burden of depression and HIV is high among people who inject drugs (PWID), yet the effect of depression on transmission risk behaviors is not well understood in this population. Using causal inference methods, we analyzed data from 455 PWID living with HIV in Vietnam 2009–2013. Study visits every 6 months over 2 years measured depressive symptoms in the past week and injecting and sexual behaviors in the prior 3 months. Severe depressive symptoms (vs. mild/no symptoms) increased injection equipment sharing (risk difference [RD] = 3.9 percentage points, 95% CI −1.7, 9.6) but not condomless sex (RD = −1.8, 95% CI −6.4, 2.8) as reported 6 months later. The cross-sectional association with injection equipment sharing at the same visit (RD = 6.2, 95% CI 1.4, 11.0) was stronger than the longitudinal effect. Interventions on depression among PWID may decrease sharing of injection equipment and the corresponding risk of HIV transmission.
Clinical trial registration ClinicalTrials.gov NCT01689545.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Mathers BM, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733–45.PubMed
2.
Mathers BM, Degenhardt L, Ali H, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375(9719):1014–28.PubMed
3.
Dutta A, Wirtz A, Stanciole A, et al. The global HIV epidemics among people who inject drugs. Washington DC: World Bank; 2013.
4.
DeHovitz J, Uuskula A, El-Bassel N. The HIV epidemic in Eastern Europe and Central Asia. Curr HIV/AIDS Rep. 2014;11(2):168–76.PubMed
5.
El-Bassel N, Shaw SA, Dasgupta A, Strathdee SA. Drug use as a driver of HIV risks. Curr Opin HIV AIDS. 2014;9(2):150–5.PubMedPubMedCentral
6.
Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J. Estimating per-act HIV transmission risk. AIDS. 2014;28(10):1509–19.PubMedPubMedCentral
7.
Thomas M, Sahu D, Raj Y, Pandey A. A probability model for estimating the force of transmission of HIV infection and its application. Am J Math Stat. 2014;4(3):171–7.
8.
Boltaev AA, El-Bassel N, Deryabina AP, et al. Scaling up HIV prevention efforts targeting people who inject drugs in Central Asia: a review of key challenges and ways forward. Drug Alcohol Depend. 2013;132(Suppl 1):S41–S4747.PubMed
9.
Larney S, Peacock A, Leung J, et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Lancet Glob Heal. 2017;5(12):e1208–e12201220.
10.
Altice FL, Azbel L, Stone J, et al. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. Lancet. 2016;388(10050):1228–48.PubMedPubMedCentral
11.
Li J, Gu J, Lau JTF, Chen H, Mo PKH, Tang M. Prevalence of depressive symptoms and associated factors among people who inject drugs in China. Drug Alcohol Depend. 2015;151:228–35.PubMed
12.
Li Y, Hershow R, Praptoraharjo I, Setiawan M, Levy J. Factors associated with symptoms of depression among injection drug users receiving antiretroviral treatment in Indonesia. J AIDS Clin Res. 2014;5(5):303.PubMedPubMedCentral
13.
Bouhnik A-D, Preau M, Vincent E, et al. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir Ther. 2005;10(1):53–61.PubMed
14.
Anagnostopoulos A, Ledergerber B, Jaccard R, et al. Frequency of and risk factors for depression among participants in the Swiss HIV Cohort Study (SHCS). PLoS ONE. 2015;10(10):1–17.
15.
Levintow SN, Pence BW, Ha TV, et al. Prevalence and predictors of depressive symptoms among HIV-positive men who inject drugs in Vietnam. PLoS ONE. 2018;13(1):e0191548.PubMedPubMedCentral
16.
Knowlton AR, Latkin CA, Schroeder JR, Hoover DR, Ensminger M, Celentano DD. Longitudinal predictors of depressive symptoms among low income injection drug users. AIDS Care. 2001;13(5):549–59.PubMed
17.
Latkin CA, Mandell W. Depression as an antecedent of frequency of intravenous drug use in an urban, nontreatment sample. Int J Addict. 1993;28(14):1601–12.PubMed
18.
Stein MD, Solomon DA, Herman DS, Anderson BJ, Miller I. Depression severity and drug injection HIV risk behaviors. Am J Psychiatr. 2003;160(9):1659–62.PubMed
19.
Treisman G, Angelino A. Interrelation between psychiatric disorders and the prevention and treatment of HIV infection. Clin Infect Dis. 2007;45(Suppl):S313–S317317.PubMed
20.
Bing EG, Burnam M, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatr. 2001;58(8):721–8.PubMed
21.
Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70(5):539–45.PubMed
22.
Nanni MG, Caruso R, Mitchell AJ, Meggiolaro E, Grassi L. Depression in HIV infected patients: a review. Curr Psychiatr Rep. 2015;17(1):1–11.
23.
Pence BW, Miller WC, Gaynes BN, Eron JJ. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2007;44(2):159–66.PubMed
24.
Lesko CR, Todd JV, Cole SR, et al. Mortality under plausible interventions on antiretroviral treatment and depression in HIV-infected women: an application of the parametric g-formula. Ann Epidemiol. 2017;27(12):783–789.e2.PubMedPubMedCentral
25.
Koblin BA, Husnik MJ, Colfax G, et al. Risk factors for HIV infection among men who have sex with men. AIDS. 2006;20(5):731–9.PubMed
26.
Storholm ED, Satre DD, Kapadia F, Halkitis PN. Depression, compulsive sexual behavior, and sexual risk-taking among urban young gay and bisexual men: the P18 cohort study. Arch Sex Behav. 2016;45(6):1431–41.PubMed
27.
Defechereux PA, Mehrotra M, Liu AY, et al. Depression and oral FTC/TDF pre-exposure prophylaxis (PrEP) among men and transgender women who have sex with men (MSM/TGW). AIDS Behav. 2016;20(7):1478–88.PubMed
28.
Fendrich M, Avci O, Johnson TP, Mackesy-Amiti ME. Depression, substance use and HIV risk in a probability sample of men who have sex with men. Addict Behav. 2013;38(3):1715–8.PubMed
29.
Lemieux AF, Nehl EJ, Lin L, Tran A, Yu F, Wong FY. A pilot study examining depressive symptoms, Internet use, and sexual risk behaviour among Asian men who have sex with men. Public Health. 2013;127(11):1041–4.PubMed
30.
Quan VM, Le MN, Ha TV, et al. Mortality and HIV transmission among male Vietnamese injection drug users. Addiction. 2011;106(3):583–9.PubMed
31.
Lancaster KE, Hoffman IF, Hanscom B, et al. Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis. J Int AIDS Soc. 2018;21(10):e25195.PubMedPubMedCentral
32.
Crepaz N, Marks G. Are negative affective states associated with HIV sexual risk behaviors? A meta-analytic review Health Psychol. 2001;20(4):291–9.PubMed
33.
Valverde EE, Purcell DW, Waldrop-Valverde D, et al. Correlates of depression among HIV-positive women and men who inject drugs. J Acquir Immune Defic Syndr. 2007;46:S96–100.PubMed
34.
Pettes T, Kerr T, Voon P, Nguyen P, Wood E, Hayashi K. Depression and sexual risk behaviours among people who inject drugs: a gender-based analysis. Sex Health. 2015;12(3):224–30.PubMedPubMedCentral
35.
Williams SC, Davey-Rothwell MA, Tobin KE, Latkin C. People who inject drugs and have mood disorders—a brief assessment of health risk behaviors. Subst Use Misuse. 2017;52(9):1175–84.
36.
O’Cleirigh C, Newcomb ME, Mayer KH, Skeer M, Traeger L, Safren SA. Moderate levels of depression predict sexual transmission risk in HIV-infected MSM: a longitudinal analysis of data from six sites involved in a prevention for positives study. AIDS Behav. 2013;17(5):1764–9.PubMedPubMedCentral
37.
Mackesy-Amiti ME, Donenberg GR, Ouellet LJ. Psychiatric correlates of injection risk behavior among young people who inject drugs. Psychol Addict Behav. 2014;28(4):1089–95.PubMedPubMedCentral
38.
Armstrong G, Jorm AF, Samson L, et al. Association of depression, anxiety, and suicidal ideation with high-risk behaviors among men who inject drugs in Delhi. India J Acquir Immune Defic Syndr. 2013;64(5):502–10.PubMed
39.
Marotta PL, Terlikbayeva A, Gilbert L, et al. Intimate relationships and patterns of drug and sexual risk behaviors among people who inject drugs in Kazakhstan: a latent class analysis. Drug Alcohol Depend. 2018;192:294–302.PubMedPubMedCentral
40.
Coyle RM, Lampe FC, Miltz AR, et al. Associations of depression and anxiety symptoms with sexual behaviour in women and heterosexual men attending sexual health clinics: a cross-sectional study. Sex Transm Infect. 2019;95(4):254–61.PubMedPubMedCentral
41.
Robins J. The control of confounding by intermediate variables. Stat Med. 1989;8(6):679–701.PubMed
42.
Fried EI, van Borkulo CD, Epskamp S, Schoevers RA, Tuerlinckx F, Borsboom D. Measuring depression over time or not? Lack of unidimensionality and longitudinal measurement invariance in four common rating scales of depression. Psychol Assess. 2016;28(11):1354–67.PubMed
43.
Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550–60.PubMed
44.
Cole SR, Hernán MA, Robins JM, et al. Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol. 2003;158(7):687–94.PubMed
45.
Bodnar LM, Davidian M, Siega-Riz AM, Tsiatis AA. Marginal structural models for analyzing causal effects of time-dependent treatments: an application in perinatal epidemiology. Am J Epidemiol. 2004;159(10):926–34.PubMed
46.
Go VF, Frangakis C, Le MN, et al. Efficacy of a multi-level intervention to reduce injecting and sexual risk behaviors among HIV-infected people who inject drugs in Vietnam: a four-arm randomized controlled trial. PLoS ONE. 2015;10(5):1–19.
47.
Ministry of Health of Vietnam. Results from the HIV/STI integrated biological and behavioral surveillance (IBBS) in Vietnam, Round II, 2009. Hanoi, Vietnam; 2011.
48.
Socialist Republic of Viet Nam. Vietnam AIDS response progress report 2014, following up the 2011 political declaration on HIV/AIDS, reporting period: January 2013-December 2013. Hanoi, Vietnam; 2014.
49.
Thai Nguyen Provincial AIDS Center. Quarterly Report of the Statistics Office of Thai Nguyen Province, Thai Nguyen Provincial AIDS Center and the Division of Social Evils Control and Prevention, Department of Labor, Invalids and Social Affairs of Thai Nguyen, Vietnam; 2007.
50.
Radloff LS. A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.
51.
Thai TT, Jones MK, Harris LM, Heard RC. Screening value of the Center for epidemiologic studies—depression scale among people living with HIV/AIDS in Ho Chi Minh City, Vietnam: a validation study. BMC Psychiatr. 2016;16(1):145.
52.
Huynh V-AN, To KG, Van Do D, To QG, Nguyen MTH. Changes in depressive symptoms and correlates in HIV people at An Hoa Clinic in Ho Chi Minh City Vietnam. BMC Psychiatr. 2017;17(1):35.
53.
Cole SR, Hernan MA. constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168(6):656–64.PubMedPubMedCentral
54.
Hernan MA, Robins JM. Estimating causal effects from epidemiological data. J Epidemiol Community Heal. 2006;60(7):578–86.
55.
Højsgaard S, Halekoh U, Yan J. The R package geepack for Generalized Estimating Equations. J Stat Softw. 2006;15(2):1–11.
56.
Yan J, Fine J. Estimating equations for association structures. Stat Med. 2004;23:859–80.PubMed
57.
Yan J. geepack: Yet another package for generalized estimating equations. R-News. 2002;2(3):12–4.
58.
Rubin D. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987.
59.
van Buuren S, Groothuis-Oudshoorn K. mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45(3):1–67.
60.
Amrhein V, Greenland S, McShane B. Scientists rise up against statistical significance. Nature. 2019;567(7748):305–7.PubMed
61.
R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2017.
62.
Allgöwer A, Wardle J, Steptoe A. Depressive symptoms, social support, and personal health behaviors in young men and women. Health Psychol. 2001;20(3):223–7.PubMed
63.
McKirnan DJ, Ostrow DG, Hope B. Sex, drugs and escape: a psychological model of HIV-risk sexual behaviours. AIDS Care. 1996;8(6):655–70.PubMed
64.
Kalichman SC. Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: implications for positive prevention interventions. Psychosom Med. 2008;70(5):593–7.PubMed
65.
Safren SA, Traeger L, Skeer MR, et al. Testing a social-cognitive model of HIV transmission risk behaviors in HIV-infected MSM with and without depression. Health Psychol. 2010;29(2):215–21.PubMedPubMedCentral
66.
Vuong DA, Van Ginneken E, Morris J, Ha ST, Busse R. Mental health in Vietnam: Burden of disease and availability of services. Asian J Psychiatr. 2011;4(1):65–70.PubMed
67.
Murphy J, Corbett KK, Linh DT, Oanh PT, Nguyen VC. Barriers and facilitators to the integration of depression services in primary care in Vietnam: a mixed methods study. BMC Health Serv Res. 2018;18(1):641.PubMedPubMedCentral
Metadaten
Titel
Estimating the Effect of Depression on HIV Transmission Risk Behaviors Among People Who Inject Drugs in Vietnam: A Causal Approach
verfasst von
Sara N. Levintow
Brian W. Pence
Kimberly A. Powers
Teerada Sripaipan
Tran Viet Ha
Viet Anh Chu
Vu Minh Quan
Carl A. Latkin
Vivian F. Go
Publikationsdatum
24.08.2020
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 2/2021
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-020-03007-9

Weitere Artikel der Ausgabe 2/2021

AIDS and Behavior 2/2021 Zur Ausgabe

Original Paper

Pre and Post-exposure Prophylaxis Awareness and Acceptability Among Sex Workers in Jamaica: A Cross-Sectional Study

Original Paper

The Impact of PrEP on the Sex Lives of MSM at High Risk for HIV Infection: Results of a Belgian Cohort

Original Paper

“As a Young Pregnant Girl… The Challenges You Face”: Exploring the Intersection Between Mental Health and Sexual and Reproductive Health Amongst Adolescent Girls and Young Women in South Africa

Original Paper

A Longitudinal, Qualitative Exploration of Perceived HIV Risk, Healthcare Experiences, and Social Support as Facilitators and Barriers to PrEP Adoption Among Black Women

Original Paper

Design and Development of a Risk Classification Instrument for Virological Failure in HIV, Using Psychosocial Determinants of Health: Preliminary Evidence from a South American Country

Original Paper

Intimate Partner Violence, HIV Pre-Exposure Prophylaxis (PrEP) Acceptability, and Attitudes About Use: Perspectives of Women Seeking Care at a Family Planning Clinic

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise